Health

Sirnaomics Announces a Partnership with Gore Range Capital for Establishment of a JV, Sagesse Bio, to Advance Its RNAi Therapeutics into Aesthetic Medicine

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, Aug. 1, 2024 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today ...

2024-08-01 11:26 1996

Sirnaomics Announces a Partnership with Gore Range Capital for Establishment of a JV, Sagesse Bio, to Advance Its RNAi Therapeutics into Aesthetic Medicine

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, Aug. 1, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, to...

2024-08-01 09:35 1736

Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA

* Following approval by the European Commission, Prestige Biopharma's Herceptin biosimilar Tuznue® would become the first biosimilar from a Singaporean company to be authorized in the European Union. SINGAPORE, Aug. 1, 2024 /PRNewswire/ -- Prestige Biopharma, a pioneer in biopharmaceuticals, a...

2024-08-01 08:00 13604

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs

BOSTON, July 31, 2024 /PRNewswire/ -- Recently, Shanghai Medicilon Inc. ("Medicilon") and Jiangsu Hengrui Pharmaceuticals Co., Ltd. ("Hengrui Pharma") reached a strategic collaboration agreement.The cooperative efforts will focus on preclinical evaluation of new drug modalities, particularly ADCs...

2024-07-31 22:39 1438

SURGLASSES Announces Successful First Clinical Implementation of Caduceus S AR Surgical Navigation System in Thailand

ONTARIO, Calif., July 31, 2024 /PRNewswire/ -- Leading augmented reality (AR) medical technology company SURGLASSES today announced that, in collaboration with exclusive distributor Goodlifeintertrade.co. Ltd., it has successfully registered and clinically implemented its AR-based Caduceus S surg...

2024-07-31 21:00 2182

Angel Yeast Driving Green Transformation Though Technological Innovation

SHANGHAI, July 31, 2024 /PRNewswire/ -- Angel Yeast (en.angelyeast.com ) (SH600298), a global leader in yeast manufacturing, is accelerating green transformation in its factory workshops by implementing a series of intelligent, automated, and sustainable technologies t...

2024-07-31 20:00 15893

PROCESSED RED MEAT RAISES THE RISK OF DEMENTIA; SWAPPING IT FOR NUTS AND BEANS MAY LOWER RISK

Four-decade study of more than 130,000 people measured the risk of your morning bacon or ballgame hot dog Key Takeaways * Eating about two servings per week of processed red meat raises the risk of dementia by 14% compared to those who eat less than approximately three servings a month. * S...

2024-07-31 19:00 1677

Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval

SHENZHEN, China, July 31, 2024 /PRNewswire/ -- On July 28 2024, Kexing Biopharm announced European Commission approval of Apexelsin®, the generic drug to Bristol Myers Squibb's and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed by WhiteOak Pharmaceutical B.V. and Kexing Biopharm is ...

2024-07-31 18:33 2099

DermRays Leads the Revolution in Home Hair Removal Devices, Set to Replace Cheap IPL

PLEASANTON, Calif., July 31, 2024 /PRNewswire/ -- DermRays, a leading innovator in skincare technology, is proud to announce its latest breakthrough, spearheading a revolution in home hair removal devices with the introduction of advanced laser technology designed to replace cheap IPL alternative...

2024-07-31 17:10 1291

JelloX Biotech collaborates with Mayo Clinic to develop AI enhanced 3D pathology imaging technology

HSINCHU, July 31, 2024 /PRNewswire/ -- JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to further develop and validate their 3D digital imaging and AI analysis technology. JelloX previously participated i...

2024-07-31 17:00 1377

Fapon Delivers Customized IVD Solutions for the US Market at ADLM 2024

CHICAGO, July 31, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is showcasing its innovative IVD total solutions at ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), fromJuly 28 to August 1 in Chicago. Committed to supporting local partners, we del...

2024-07-31 14:42 1232

Australian tech leading new digital biosecurity infrastructure

SYDNEY, July 31, 2024 /PRNewswire/ -- With highly pathogenic avian influenza expected to hit our shores in as little as six weeks, a real time biosecurity threat management system will be critical to response and recovery, according to Adrian Turner, co-founder of Australian tech startup ExoFlare....

2024-07-31 11:32 2043

FDA Grants Orphan Drug Designation (ODD) Status to Zymedi's ZMA001 for Pulmonary Arterial Hypertension

INCHEON, South Korea, July 30, 2024 /PRNewswire/ -- Zymedi (CEO Sunghoon Kim) announced that its first-in-class antibody treatment ZMA001, currently in development for pulmonary arterial hypertension (PAH), has been designated as an Orphan Drug by the U.S. Food and Drug Administration (FDA). Pul...

2024-07-31 08:00 1640

Porton Advanced and Geneseed Biotech Enter into Strategic Collaboration to Focus on Advancing circRNA Innovative Therapeutics

SUZHOU, China, July 30, 2024 /PRNewswire/ -- On July 29, 2024, Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Biotech"). Both sides will combine their respective strengths in the field of gene...

2024-07-30 22:00 2385

Connext Successfully Administers First Dose of CNT201 for Dupuytren's Contracture

World's First Genetically Recombinant Collagenase Therapeutics (CNT201) Begins Clinical Trials inAustralia SEOUL, South Korea, July 30, 2024 /PRNewswire/ -- Connext has announced the successful first administration of CNT201, its therapeutic treatment for Dupuytren's contracture, in patients. D...

2024-07-30 21:00 2259

Sengenics Corporation Unveils i-Ome® Cancer: A Breakthrough in Cancer Precision Medicine

Revolutionizing Biomarker Discovery with a High-Throughput Immunoproteomic Platform BOSTON, July 30, 2024 /PRNewswire/ -- Sengenics Corporation LLC is proud to announce the launch of i-Ome Cancer, a cutting-edge research tool designed to transform cancer biomarker discovery using just a drop of ...

2024-07-30 20:30 1744

GLP-1 DRUG LIRAGLUTIDE MAY PROTECT AGAINST DEMENTIA

Key Takeaways * A GLP-1 agonist — the class of drugs shown to help with diabetes and weight loss and reduce the risk of heart disease — also may protect the brain. * In a Phase 2b trial, liraglutide appears to reduce shrinking in the parts of the brain that control memory, learning, language ...

2024-07-30 19:00 1783

Sedafiat Sdn. Bhd. Claims Victory with Corporate Excellence Award at the Asia Pacific Enterprise Awards 2024 Malaysia

SINGAPORE, July 30, 2024 /PRNewswire/ -- Sedafiat Sdn. Bhd. was honored with the prestigious Corporate Excellence Award at the Asia Pacific Enterprise Awards (APEA) 2024 Malaysia. Organized annually across 16 markets by Enterprise Asia, APEA serves asAsia's premier award networking platform. A ni...

2024-07-30 17:11 2147

Baird Medical Announces Engagement and Education Program for the Development of Thyroid Microwave Ablation Technology

FRISCO, Texas, July 30, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical"), a leading developer and provider of microwave ablation ("MWA") medical devices inChina and the United States, today announced a cross-market engagement and education program designed at fostering both kno...

2024-07-30 17:00 1684

Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence

Empowering biopharma with enhanced safety insights to anticipate risks and unlock new competitive advantages LONDON, July 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the launch of the newOFF-X™ platform. The enhance...

2024-07-30 15:00 1561
1 ... 49505152535455 ... 858